SKI-349, a Sphingosine Kinases 1/2 Inhibitor, Suppresses Cell Viability, Invasion, and AKT/mTOR Signaling Pathway, and Shows Synergistic Cytotoxic Effects with Sorafenib in Hepatocellular Carcinoma

  • Tohoku J Exp Med. 2023 Dec 21. doi: 10.1620/tjem.2023.J100.
Liqiao Chen  1 ,  Liangliang Wang  1 ,  Zongqi Han  1 ,  Peng Qin  2 ,  Guangxu Niu  3 ,  Jingxia Du  1
Affiliations
  • 1. Department of Basic Medical, Xingtai Medical College.
  • 2. Department of Vascular Intervention, The Second Affiliated Hospital of Xingtai Medical College.
  • 3. Department of Pathology, Handan Central Hospital.
PMID: 38123304 DOI: 10.1620/tjem.2023.J100
Products